Ignite Creation Date:
2024-05-06 @ 4:10 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04898387
Status:
COMPLETED
Last Update Posted:
2023-07-21
First Post:
2021-05-04
Brief Title:
Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort UD in Ocular Hypertensive or Glaucomatous Patients
Sponsor:
Laboratoires Thea
Organization:
Laboratoires Thea
Study Overview
Official Title:
Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort UD in Ocular Hypertensive or Glaucomatous Patients
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To demonstrate the non-inferiority of T4030 unpreserved eye drops compared to Ganfort UD in terms of efficacy
Detailed Description:
Efficacy Parameters IOP assessment in each eye
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None